Home » Trials » SLCTR/2014/010


Prophylactic use of antibiotic (doxycycline) for incomplete and missed miscarriage, prior to medical and surgical management

-

SLCTR Registration Number

SLCTR/2014/010


Date of Registration

26 May 2014

The date of last modification

Apr 30, 2019


Trial Status



Application Summary


Scientific Title of Trial

Prophylactic use of antibiotic (doxycycline) for incomplete and missed miscarriage, prior to medical and surgical management


Public Title of Trial

A study on antibiotic use to prevent infections after miscarriage


Disease or Health Condition(s) Studied

Incomplete and missed miscarriage


Scientific Acronym

None


Public Acronym

None


Brief title

None


Universal Trial Number

None


Any other number(s) assigned to the trial and issuing authority

None


Trial Details


What is the research question being addressed?

What is the effectiveness of prophylactic doxycycline use compared to placebo, given prior to surgical and medical evacuation of incomplete and missed miscarriage, in decreasing post-operative pelvic infection?


Type of study

Interventional


Study design

Allocation

Randomized controlled trial


Masking

Single blinded


Control

Placebo


Assignment

Parallel


Purpose

Prevention


Study Phase

Phase 4


Intervention(s) planned

Prospective participants presenting to the study setting will be evaluated by the Principal Investigator. Medical or surgical management will be decided on the following criteria

1) Patients presenting with per vaginal bleeding, os-open, Trans vaginal ultrasound (TVS) detecting incomplete miscarriage will be selected to receive surgical evacuation or medical evacuation depending on patient preference. If medical management fails, surgical evacuation will be offered.

2) Patients diagnosed with missed miscarriage, os- closed with compatible TVS findings will be offered medical management. If medical management fails, surgical evacuation will be offered.

Once management has been decided, consenting participants meeting the inclusion/exclusion criteria will be recruited for the study. Stratified randomization with computer generated random numbers will be used to allocate participants to two arms.

The intervention arm will receive a single oral dose of doxycycline 200mg one hour prior to intervention. The control arm will receive an inert placebo, with identical appearance to doxyclycline.

Other interventions such as dilatation & curettage, vacuum aspiration/suction evacuation, medical management with vaginal prostaglandin use and blood transfusion will be provided to both arms as indicated.


Inclusion criteria

Woman who present to ward NO: 03, T.H .Peradeniya (Gynaecology Professorial Unit) with incomplete and missed miscarriage diagnosed by Trans vaginal ultrasound as below:
1. Incomplete miscarriage: thickness of products of conception is > 1.5 cm
2. Missed miscarriage: Gestational sac >25mm without fetal pole or fetal pole CRL> 7mm without heart beat


Exclusion criteria

  1. Signs and symptoms of infection including • Temperature > 37 0C • Lower abdominal tenderness • Offensive vaginal discharge • Cervical excitation

  2. Known allergy to doxycycline

  3. POG=/< than 24 weeks.



Primary outcome(s)

1.

Clinical signs of infection (at least 3 of the following)

  1. In the history: fever, chills, headache, lower abdominal pain and smelly vaginal discharge.
  2. Temperature >37 degrees C.
  3. Lower abdominal tenderness.
  4. Positive cervical excitation test with or without adenexial tenderness.
  5. Presence of smelly vaginal discharge.
[

At completion of three days and at 2 weeks post intervention

]

Secondary outcome(s)

1.

None

[

None

]

Target number/sample size

280 (140 in each arm)


Countries of recruitment

Sri Lanka


Anticipated start date

2014-05-26


Anticipated end date

2014-12-31


Date of first enrollment

2014-05-26


Date of study completion


Recruitment status

Recruiting


Funding source

None


Regulatory approvals



State of Ethics Review Approval


Status

Approved


Date of Approval

2013-12-10


Approval number

N/A


Details of Ethics Review Committee

Name: Ethics Review Committee, Faculty of Medicine, University of Peradeniya
Institutional Address:Galaha Road, Kandy, Sri Lanka
Telephone:+94-812396361
Email: chairpersonierc@gmail.com

Contact & Sponsor Information


Contact person for Scientific Queries/Principal Investigator

Dr. D.P.G.G.M. Prasanga
Registrar, Gynaecology and Obstetrics
Professorial Unit, Teaching Hospital, Peradeniya.

0772988313

prasangagayan@yahoo.com

Contact Person for Public Queries

Dr C Rathnayake
Consultant Obstetrician and Gynaecologist and Senior Lecturer in Obstetrics and Gynaecology
Faculty of Medicine, University of Peradeniya

0777792616

chathura.ratnayake@gmail.com


Primary study sponsor/organization

University Obstetrics and Gynaecology Unit,

Faculty of Medicine, University of Peradeniya
Tel: 081-2388840
Fax :081-2389106

http://www.pdn.ac.lk/med/departments/gyn&obs/index.html

Secondary study sponsor (If any)

None





Trial Completion details


Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?


IPD sharing plan description


Study protocol available


Protocol version and date

Not Available


Protocol URL

Not Available


Results summary available

No


Date of posting results


Date of study completion


Final sample size


Date of first publication


Link to results


Brief summary of results